Navigation Links
Ganeden Biotech Hires New Marketing Manager
Date:12/10/2012

Cleveland, OH (PRWEB) December 10, 2012

Ganeden Biotech®, a recognized world leader in the manufacturing and marketing of probiotics, announced today that Erin Miller has joined the company as Marketing Manager.

“Erin is very digitally savvy and her keen sense and understanding of proactive marketing will help drive Ganeden’s expansion efforts in 2013 and beyond,” said Mike Bush, Vice President of Business Development, Ganeden Biotech. “Ganeden is fortunate to have Erin on its team.”

In her role as Marketing Manager, Miller will lead Ganeden Biotech’s marketing and communications efforts for its GanedenBC30 and Bonicel brands – both branded probiotic and/or probiotic-derived ingredients. Her responsibilities include overseeing public and media relations, distributor communications, advertising, website development, and tradeshow planning. She will also provide support to the Ganeden sales team by way of strategic planning, market research, direct mail and email marketing, customer communications and lead generation.

Prior to joining Ganeden Biotech, Miller spent the majority of her career in publishing, and specifically, the last eight years with Crain’s Cleveland Business as Audience Development and Retention Manager. In this role she was solely responsible for growing paid print and free digital readers for both Crainscleveland.com and Crain’s Cleveland, the print edition. She managed to grow the online subscriber base by 400 percent during the course of her tenure and was instrumental in creating a social media network.

Prior to joining Crain’s, Miller lived in New York where she held marketing positions with YM and Fitness magazines (Gruner + Jahr USA), and Primedia – Consumer Media and Magazine Group.

Miller has served prominent roles with the Cleveland Chapter of the American Marketing Associati
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Probiotic-Enriched Instant Chai Latte and Teas to be Launched by Ganeden Biotech and Tipton Mills
2. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
3. Puma Biotechnology Announces Completion of Private Placement
4. Animal Biotechnology - Technologies, Markets and Companies
5. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
6. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
7. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
8. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
9. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
10. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
11. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Mass. , Feb. 27, 2015 ... of the NCATS rare-diseases portfolio " in ... a new financing technique to reduce the risk ... diseases and potentially unlock new levels of funding ... The product of a unique collaboration between scientists ...
(Date:2/27/2015)... Md. (PRWEB) February 27, 2015 ... Chromatography system (Nexera UC) can sequentially analyze up ... separation combined with high-sensitivity detection of targets by ... is designed to fulfill the measurement requirements of ... in food products, drug delivery and search for ...
(Date:2/27/2015)... Brighton, Illinois (PRWEB) February 27, 2015 ... Matt Sims, General Manager of State Line Farms, received ... Award recognizes a producer, under the age of 35, ... , "It is an honor to win the Tomorrow's ... to discovering who won the Top Producer Award and ...
(Date:2/27/2015)... BOSTON , Feb. 27, 2015   PureTech ... identifying, inventing and commercializing disruptive products and technologies in ... Christopher Viehbacher , former CEO and Member of the ... Directors.  "It,s has been a pleasure ... very excited that we will be working together more ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4
... S.C., Aug. 6 Denham Capital,("Denham") announced ... $60 million in VitAG,Corporation ("VitAG"). VitAG technology ... product capable of competing with and,outperforming conventional ... multiple biosolids-to-fertilizer manufacturing plants., "Denham,s investment ...
... Million; GAAP EPS $0.53; Adjusted EPS $0.48, CORONA, ... ), a leading specialty pharmaceutical,company, today reported financial results ... Quarter 2008 Results, Net revenue for the second ... million, or $0.53 per diluted share. Net income for ...
... on Tuesday, August 12, 2008, ROCKVILLE, Md., ... a clinical-stage pharmaceutical company developing,therapeutics for the treatment ... for the three and six-month periods ending June,30, ... The Company reported a net loss for the ...
Cached Biology Technology:Denham Capital to Invest $60 Million in VitAG, Recycler of Municipal Biosolids 2Watson Pharmaceuticals Reports Second Quarter 2008 Results 2Watson Pharmaceuticals Reports Second Quarter 2008 Results 3Watson Pharmaceuticals Reports Second Quarter 2008 Results 4Watson Pharmaceuticals Reports Second Quarter 2008 Results 5Watson Pharmaceuticals Reports Second Quarter 2008 Results 6Watson Pharmaceuticals Reports Second Quarter 2008 Results 7Watson Pharmaceuticals Reports Second Quarter 2008 Results 8Watson Pharmaceuticals Reports Second Quarter 2008 Results 9Watson Pharmaceuticals Reports Second Quarter 2008 Results 10Watson Pharmaceuticals Reports Second Quarter 2008 Results 11Watson Pharmaceuticals Reports Second Quarter 2008 Results 12Watson Pharmaceuticals Reports Second Quarter 2008 Results 13Watson Pharmaceuticals Reports Second Quarter 2008 Results 14Watson Pharmaceuticals Reports Second Quarter 2008 Results 15Watson Pharmaceuticals Reports Second Quarter 2008 Results 16Watson Pharmaceuticals Reports Second Quarter 2008 Results 17EntreMed Reports Second Quarter 2008 Financial Results 2EntreMed Reports Second Quarter 2008 Financial Results 3EntreMed Reports Second Quarter 2008 Financial Results 4EntreMed Reports Second Quarter 2008 Financial Results 5
(Date:1/22/2015)... 2015  Today, FreeWavz ( www.FreeWavz.com ), the developer ... on Fundable, https://www.fundable.com/freewavz . FreeWavz will be ... to meet customer demand. Logo - ... Invented by Dr. ...
(Date:1/22/2015)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a biometric ... recent success of the Wocket™ smart wallet at CES 2015 in ... named as one of the "11 Hot Products at CES" in a ... CES So Far" by Newseveryday.com and "The top 10 gadgets from CES ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) has ... Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, ... report to their offering. , ... be worn on the user,s body and have ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... that it has been named an American Society ... Center of Excellence. The ASMBS Center of ... track record of favorable outcomes in bariatric surgery. ... of our experienced surgeons and our institutional commitment ...
... lakes and even wet soil, diatoms are unicellular algae ... these tiny phytoplankton could be harboring the next big ... walls by laying down submicron-sized lines of silica, a ... industrysilicon. If we can genetically control that process, we ...
... study by the University of Exeter has highlighted ... for conservation projects. Published online in the journal ... rates of captive carnivores that are released into ... three captive-born carnivores survives in the wild, with ...
Cached Biology News:Pennsylvania Hospital recognized for excellence in bariatric surgery 2In diatom, scientists find genes that may level engineering hurdle 2Captive carnivores not up to wild living 2
... multi-purpose, high gel-strength agarose suitable for a ... conventional constant field to Pulsed Field Gel ... strength and exclusion limits, Multi ABgarose can ... running times. This in turn means reduced ...
... molecular screening, low melting point agarose where ... is recommended for separation of nucleic acids ... PCR products. Micro ABgarose is also suited ... for blotting techniques. At a 3% concentration, ...
Sheep polyclonal to Salmonella Shoreditch ( Abpromise for all tested applications). Antigen: Native Salmonella shoreditch (Group D2)....
anti-achaete...
Biology Products: